SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alice B. Kornblith, PhD
Dana-Farber Cancer Institute
Study Chair - Patricia A. Ganz, MD
Jonsson Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Ellis Fischel Cancer Center - Columbia
Columbia, Missouri, United States
- Barnes-Jewish Hospital
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Beth Israel Medical Center
New York, New York, United States
- State University of New York - Upstate Medical University
Syracuse, New York, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- University of Tennessee, Memphis Cancer Center
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 1994
- Primary completion
- 30 Sept 2003
- Completion
- 31 May 2005
- Last update posted
- 10 Apr 2013
- Registered enrollment
- 263
- Registry id
- NCT00002563
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.